| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $31.5M | -15.0% |
| Cost of Revenue | $20.0M | +306.1% |
| Gross Profit | $11.4M | -64.4% |
| R&D Expense | $45.5M | -2.7% |
| SG&A Expense | $609.8M | +703.4% |
| Operating Income | -$689.6M | -397.1% |
| Pre-tax Income | -$664.1M | -91.7% |
| Income Tax | $322K | -83.4% |
| Net Income | -$355.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $836.4M | +108.3% |
| Short-term Investments | $417.8M | +944.5% |
| Accounts Receivable | $8.4M | -60.3% |
| Current Assets | $1.27B | +170.1% |
| Total Assets | $1.41B | +159.3% |
| Current Liabilities | $296.1M | +230.0% |
| Total Liabilities | $299.0M | +226.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$459.6M | -323.0% |
| Capital Expenditures | $508K | +1054.5% |
| Investing Cash Flow | -$411.3M | -932.1% |
| Financing Cash Flow | $1.31B | +203.8% |
| Free Cash Flow | -$460.1M | -323.3% |
| -160.4% |
| EPS (Basic) | -$2.17 | -47.6% |
| EPS (Diluted) | -$2.17 | -47.6% |
| Stockholders' Equity |
| $1.17B |
| +88.9% |